作者：
Okines,A.F.C. [1]
;
Langley,R.E. [2]
;
Thompson,L.C. [3]
;
Stenning,S.P. [4]
;
Stevenson,L. [5]
;
Falk,S. [6]
;
Seymour,M. [7]
;
Coxon,F. [8]
;
Middleton,G.W. [9]
;
Smith,D. [10]
;
Evans,L. [11]
;
Slater,S. [12]
;
Waters,J. [13]
;
Ford,D. [14]
;
Hall,M. [15]
;
Iveson,T.J. [16]
;
Petty,R.D. ;
Plummer,C. ;
Allum,W.H. ;
Blazeby,J.M. ;
Griffin,M. ;
Cunningham,D.
作者单位：
Department of Oncology, The Clatterbridge Cancer Centre NHS Foundation Trust, Clatterbridge, United
[1]
Kent Oncology Centre, Maidstone Hospital, Maidstone, United Kingdom
[2]
Department of Medical Oncology, Weston Park Hospital, Sheffield, United Kingdom
[3]
Department of Oncology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom
[4]
University of Leeds, St James's Hospital, Leeds, United Kingdom
[5]
Department of Surgery, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
[6]
Clinical Trials Unit, Medical Research Council, London, United Kingdom
[7]
Department of Medical Oncology, Freeman Hospital, Newcastle upon Tyne, United Kingdom
[8]
University of Southampton Medical School-Cancer Research UK Clinical Centre, Southampton, United
[9]
Clinical Oncology, Bristol Haematology and Oncology Centre, Bristol, United Kingdom
[10]
Department of Oncology, St. Bart's Hospital, London, United Kingdom
[11]
Department of Medical Oncology, Royal Surrey County Hospital, Guildford, United Kingdom
[12]
Department of Oncology, Queen Elizabeth Hospital, Birmingham, United Kingdom
[13]
Department of Surgery, University of Bristol, Bristol, United Kingdom
[14]
Department of Medical Oncology, Wexham Park Hospital, Northwood, United Kingdom
[15]
Department of Medicine, Royal Marsden Hospital NHS Foundation Trust London and Surrey, London
[16]
发布时间
2013-11-20
换一批
